Analyst Summary
Fischer Medical Ventures Ltd operates in the Chemicals - Inorganic - Others segment, NSE: FISCHER | BSE: 524743, current market price is ₹41.20, market cap is 2,695 Cr.. At a glance, stock P/E is 68.1, ROE is 0.70 %, ROCE is 1.08 %, book value is 5.55, dividend yield is 0.01 %. The latest intrinsic value estimate is ₹5.15, around 87.5% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹111 Cr versus the prior period change of 428.6%, while latest net profit is about ₹1 Cr with a prior-period change of -50.0%. The 52-week range shown on this page is 125/32.0, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisFischer Medical Ventures Ltd. is a Public Limited Listed company incorporated on 22/03/1993 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(…
This summary is generated from the stock page data available for Fischer Medical Ventures Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.
Investment Snapshot
Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.
Share Price and Basic Stock Data
Last Updated: April 2, 2026, 4:36 am
| PEG Ratio | 4.10 |
|---|
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,695 Cr. | 41.2 | 125/32.0 | 68.1 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Vishnu Chemicals Ltd | 3,347 Cr. | 497 | 596/336 | 24.3 | 149 | 0.06 % | 18.1 % | 15.5 % | 2.00 |
| A-1 Acid Ltd | 767 Cr. | 16.7 | 70.4/11.6 | 311 | 1.06 | 0.22 % | 10.6 % | 7.82 % | 1.00 |
| Sree Rayalaseema Hi-Strength Hypo Ltd | 707 Cr. | 412 | 717/381 | 6.86 | 588 | 0.73 % | 14.9 % | 11.0 % | 10.0 |
| Alufluoride Ltd | 333 Cr. | 425 | 491/376 | 14.0 | 144 | 0.71 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,204.50 Cr | 338.20 | 82.73 | 156.25 | 0.59% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 21 | 10 | 40 | 12 | 49 | 23 | 86 | 101 |
| Expenses | 0 | 18 | 10 | 39 | 11 | 47 | 19 | 70 | 80 |
| Operating Profit | 0 | 3 | -0 | 0 | 0 | 2 | 4 | 16 | 22 |
| OPM % | 12% | -2% | 1% | 3% | 5% | 18% | 19% | 21% | |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 3 | 0 | 0 | 0 | 2 | 10 | 17 | 21 |
| Tax % | 6% | 271% | -38% | 350% | 28% | 51% | 19% | 9% | |
| Net Profit | 0 | 3 | -0 | 0 | -0 | 1 | 5 | 14 | 19 |
| EPS in Rs | 0.00 | 0.05 | -0.00 | 0.01 | -0.01 | 0.02 | 0.08 | 0.21 | 0.30 |
Last Updated: February 2, 2026, 12:16 am
Profit & Loss - Annual Report
Last Updated: February 27, 2026, 5:15 am
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Sales | 0 | 21 | 111 | 260 |
| Expenses | 0 | 19 | 108 | 216 |
| Operating Profit | 0 | 2 | 3 | 44 |
| OPM % | 11% | 9% | 3% | 17% |
| Other Income | 0 | 0 | 1 | 11 |
| Interest | 0 | 0 | 0 | 2 |
| Depreciation | 0 | 0 | 2 | 3 |
| Profit before tax | 0 | 2 | 2 | 50 |
| Tax % | 13% | 45% | ||
| Net Profit | -0 | 2 | 1 | 39 |
| EPS in Rs | -0.24 | 0.03 | 0.02 | 0.61 |
| Dividend Payout % | 0% | 0% | 22% |
Growth
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:52 am
| Month | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|
| Equity Capital | 0.17 | 54 | 64 | 65 |
| Reserves | -0 | 28 | 274 | 295 |
| Borrowings | 1 | 2 | 85 | 30 |
| Other Liabilities | 0 | 4 | 34 | 77 |
| Total Liabilities | 0 | 86 | 457 | 468 |
| Fixed Assets | 0 | 15 | 24 | 31 |
| CWIP | 0 | 0 | 1 | 2 |
| Investments | 0 | 1 | 11 | 121 |
| Other Assets | 0 | 70 | 421 | 313 |
| Total Assets | 0 | 86 | 457 | 468 |
Cash Flow
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Free Cash Flow
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Free Cash Flow | -1.00 | 0.00 | -82.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 345 | 398 | 251 |
| Inventory Days | 36 | ||
| Days Payable | 82 | ||
| Cash Conversion Cycle | 345 | 398 | 205 |
| Working Capital Days | 324 | 498 | 107 |
| ROCE % | 5% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.08 | 1.65 | -2.12 |
| Diluted EPS (Rs.) | 0.08 | 1.08 | -2.12 |
| Cash EPS (Rs.) | 0.52 | 0.37 | -2.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 52.90 | 15.16 | -15.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 52.90 | 15.16 | -15.47 |
| Revenue From Operations / Share (Rs.) | 17.35 | 3.92 | 10.44 |
| PBDIT / Share (Rs.) | 0.75 | 0.44 | 0.88 |
| PBIT / Share (Rs.) | 0.50 | 0.40 | 0.88 |
| PBT / Share (Rs.) | 0.42 | 0.39 | -0.07 |
| Net Profit / Share (Rs.) | 0.26 | 0.34 | -2.12 |
| NP After MI And SOA / Share (Rs.) | 0.18 | 0.34 | -2.12 |
| PBDIT Margin (%) | 4.36 | 11.25 | 8.46 |
| PBIT Margin (%) | 2.89 | 10.38 | 8.46 |
| PBT Margin (%) | 2.44 | 10.06 | -0.72 |
| Net Profit Margin (%) | 1.53 | 8.75 | -20.33 |
| NP After MI And SOA Margin (%) | 1.09 | 8.75 | -20.33 |
| Return on Networth / Equity (%) | 0.35 | 2.26 | 0.00 |
| Return on Capital Employeed (%) | 0.90 | 2.64 | 4.97 |
| Return On Assets (%) | 0.26 | 2.12 | -10.32 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | -2.15 |
| Total Debt / Equity (X) | 0.17 | 0.00 | -2.15 |
| Asset Turnover Ratio (%) | 0.40 | 0.48 | 0.00 |
| Current Ratio (X) | 3.59 | 18.37 | 5.18 |
| Quick Ratio (X) | 3.50 | 17.20 | 5.18 |
| Inventory Turnover Ratio (X) | 16.23 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 9.80 | 34.92 | 0.92 |
| Interest Coverage Ratio (Post Tax) (X) | 4.43 | 28.19 | -1.21 |
| Enterprise Value (Cr.) | 5536.85 | 3303.93 | 1.98 |
| EV / Net Operating Revenue (X) | 50.02 | 157.47 | 11.03 |
| EV / EBITDA (X) | 1145.02 | 1399.44 | 130.31 |
| MarketCap / Net Operating Revenue (X) | 51.74 | 159.28 | 8.05 |
| Price / BV (X) | 16.97 | 41.20 | -5.43 |
| Price / Net Operating Revenue (X) | 51.74 | 159.31 | 8.05 |
| EarningsYield | 0.00 | 0.00 | -0.02 |
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Medical Equipment & Accessories | Survey No. 480/2 AP Medtech Zone, Nadupura Village, Vishakapatnam Andhra Pradesh 530032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravindran Govindan | Chairman & Managing Director |
| Ms. Svetlana Rao | Whole Time Executive Director |
| Mr. Sanjay Jayantilal Jain | Independent Director |
| Mr. Jaya Ankur Singhania | Independent Director |
| Mr. Khairy Jamaluddin Abu Bakkar | Independent Director |
| Mr. Roberto M Pagdanganan | Independent Director |
FAQ
What is the intrinsic value of Fischer Medical Ventures Ltd and is it undervalued?
As of 22 April 2026, Fischer Medical Ventures Ltd's intrinsic value is ₹5.15, which is 87.50% lower than the current market price of ₹41.20, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (0.70 %), book value (₹5.55), dividend yield (0.01 %), and 5-year EPS CAGR.
What is the current share price and 52-week range of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd is trading at ₹41.20 as of 22 April 2026, with a FY2026-2027 high of ₹125 and low of ₹32.0. The stock is currently near its 52-week low. Market cap stands at ₹2,695 Cr..
How does Fischer Medical Ventures Ltd's P/E ratio compare to its industry?
Fischer Medical Ventures Ltd has a P/E ratio of 68.1, which is below the industry average of 82.73. This is broadly in line with or below the industry average.
Is Fischer Medical Ventures Ltd financially healthy?
Key indicators for Fischer Medical Ventures Ltd: ROCE of 1.08 % is on the lower side compared to the industry average of 13.95%; ROE of 0.70 % is below ideal levels (industry average: 10.65%). Dividend yield is 0.01 %.
Is Fischer Medical Ventures Ltd profitable and how is the profit trend?
Fischer Medical Ventures Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹111 Cr. Compared to ₹0 Cr in Mar 2023, the net profit shows an improving trend.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd has a dividend yield of 0.01 % at the current price of ₹41.20. The company pays dividends, though the yield is modest.
